ReviewJournal of medical Internet research2025
Artificial Intelligence in Health Promotion and Disease Reduction: Rapid Review.
Review in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- User Acceptability and Adoption of AI-Generated Lifestyle Intervention Recommendations: Scoping Review and Theoretical Integration.Journal of medical Internet research · 2026Article
- Artificial Intelligence for Weight Management in Children: A Narrative Review.Healthcare (Basel, Switzerland) · 2026Review
- Digital hypertension in 2024-2025: emerging evidence and future directions.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Review
- Facilitators and Barriers of Using an Artificial Intelligence Agent in Chronic Disease Management: A Normalization Process Theory-Guided Qualitative Study of Older Patients with COPD.Healthcare (Basel, Switzerland) · 2026Article
- Integrating Artificial Intelligence (AI) in Primary Health Care (PHC) Systems: A Framework-Guided Comparative Qualitative Study.Healthcare (Basel, Switzerland) · 2026Article
- Is it Time to Better Harness Artificial Intelligence for Improving Lifestyle Behaviours?International journal of public health · 2026Article
- Artificial Intelligence and the future of clinical trials.Contemporary clinical trials communications · 2025Article
- Artificial Intelligence in Health Promotion and Disease Reduction: Rapid Review.Journal of medical Internet research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic diseases represent a significant global burden of mortality, exacerbated by behavioral risk factors. Artificial intelligence (AI) has transformed health promotion and disease reduction through improved early detection, encouraging healthy lifestyle modifications, and mitigating the economic strain on health systems. Objective: The aim of this study is to investigate how AI contributes to health promotion and disease reduction among Organization for Economic Co-operation and Development countries. Methods: We conducted a rapid review of the literature to identify the latest evidence on how AI is used in health promotion and disease reduction. We applied comprehensive search strategies formulated for MEDLINE (OVID) and CINAHL to locate studies published between 2019 and 2024. A pair of reviewers independently applied the inclusion and exclusion criteria to screen the titles and abstracts, assess the full texts, and extract the data. We synthesized extracted data from the study characteristics, intervention characteristics, and intervention purpose using structured narrative summaries of main themes, giving a portrait of the current scope of available AI initiatives used in promoting healthy activities and preventing disease. Results: We included 22 studies in this review (out of 3442 publications screened), most of which were conducted in the United States (10/22, 45%) and focused on health promotion by targeting lifestyle dimensions, such as dietary behavior (10/22, 45%), smoking cessation (6/22, 27%), physical activity (4/22, 18%), and mental health (3/22, 14%). Three studies targeted disease reduction related to metabolic health (eg, obesity, diabetes, hypertension). Most AI initiatives were AI-powered mobile apps. Overall, positive results were reported for process outcomes (eg, acceptability, engagement), cognitive and behavioral outcomes (eg, confidence, step count), and health outcomes (eg, glycemia, blood pressure). We categorized the challenges, benefits, and suggestions identified in the studies using a Strengths, Weaknesses, Opportunities, and Threats analysis to inform future developments. Key recommendations include conducting further investigations, taking into account the needs of end users, improving the technical aspect of the technology, and allocating resources. Conclusions: These findings offer critical insights into the effective implementation of AI for health promotion and disease prevention, potentially guiding policymakers and health care practitioners in optimizing the use of AI technologies in supporting health promotion and disease reduction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.